How Smith was paid
$27M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Ian F. SmithChief Executive Officer | $170,625 | $1,197,125 | $11,590,000 | $14,035,067 | — | $38,838 | $27,031,655 |
| Thomas LeggettChief Financial Officer | $496,375 | — | $491,470 | $534,881 | $297,825 | $9,824 | $1,830,375 |
| Jason HoittChief Patient Officer | $494,401 | — | $333,200 | $1,121,337 | $306,000 | $15,017 | $2,269,955 |
| Edward M. Kaye, M.D.Former Chief Executive Officer | $148,726 | — | $1,199,520 | $1,298,138 | — | $587,658 | $3,234,043 |
What changed and why
- $27MIan F. Smith received total compensation of $27,031,655 following his appointment as Chief Executive Officer in 2025.
- 150%Corporate performance goals for 2025 were determined to have been achieved at a 150% multiplier level.
- 4.5%Thomas Leggett received a 2025 base salary of $496,375, representing a 4.5% increase from the prior year.
- $510KJason Hoitt received a 2025 base salary of $510,000 following his promotion to Chief Patient Officer.
- $3.2MFormer Chief Executive Officer Edward M. Kaye, M.D. received total compensation of $3,234,043 for 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.